Chen PJ, Hussmann JA, Yan J, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184(22):5635-5652.e29. doi:10.1016/j.cell.2021.09.018.

Raj L, Ide T, Gurkar AU, et al. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 2011;475(7355):231-4. doi:10.1038/nature10167.

Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL, Crabtree GR. Signal transduction in T lymphocytes using a conditional allele of Sos. Proc Natl Acad Sci U S A. 1995;92(21):9810-4.

Vetere A, Donati I, Campa C, Semeraro S, Gamini A, Paoletti S. Synthesis and characterization of a novel glycopolymer with protective activity toward human anti-alpha-Gal antibodies. Glycobiology. 2002;12(4):283-90.

Younger ST, Rinn JL. p53 regulates enhancer accessibility and activity in response to DNA damage. Nucleic Acids Res. 2017;45(17):9889-9900. doi:10.1093/nar/gkx577.

Stump B, Shrestha S, Lamattina AM, et al. Glycogen synthase kinase 3-β inhibition induces lymphangiogenesis through β-catenin-dependent and mTOR-independent pathways. PLoS One. 2019;14(4):e0213831. doi:10.1371/journal.pone.0213831.

Galonska C, Charlton J, Mattei AL, et al. Genome-wide tracking of dCas9-methyltransferase footprints. Nat Commun. 2018;9(1):597. doi:10.1038/s41467-017-02708-5.

Belshaw PJ, Ho SN, Crabtree GR, Schreiber SL. Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci U S A. 1996;93(10):4604-7.

Ho SN, Boyer SH, Schreiber SL, Danishefsky SJ, Crabtree GR. Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists. Proc Natl Acad Sci U S A. 1994;91(20):9203-7.

Zamora CY, Ryan MJ, d’Alarcao M, Kumar K. Sialidases as regulators of bioengineered cellular surfaces. Glycobiology. 2015;25(7):784-91. doi:10.1093/glycob/cwv019.